TG Therapeutics, Inc. (TGTX)
Healthcare • Biotechnology
StockNasdaqCMUnited StatesUS88322Q1085
64.56 USD
-1.82% today Updated 13 Nov 2026 10:48
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by TG Therapeutics, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 10:48. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Next results
01 Mar 2027
in 108 days · 08:00 · estimate 0.60
Last results
0.35 vs 0.26 estimated
09 Nov 2026 · Beat +35.9%
Beat the estimate
3 of 12
9 missed · 0 in line
Average surprise
-15.2%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 01 Mar 2027 08:00 | 0.60 | — | — | Upcoming |
| 09 Nov 2026 07:00 | 0.26 | 0.35 | +35.9% | Beat |
| 03 Aug 2026 07:00 | 0.44 | 0.05 | -88.6% | Miss |
| 06 May 2026 07:00 | 0.28 | 0.18 | -35.1% | Miss |
| 26 Feb 2026 07:00 | 0.33 | 0.14 | -57.5% | Miss |
| 03 Nov 2025 07:00 | 0.22 | 0.16 | -26.3% | Miss |
| 04 Aug 2025 07:00 | 0.29 | 0.17 | -40.9% | Miss |
| 05 May 2025 07:00 | 0.17 | 0.03 | -82.8% | Miss |
| 03 Mar 2025 07:00 | 0.17 | 0.15 | -12.3% | Miss |
| 04 Nov 2024 07:00 | 0.03 | 0.02 | -40.9% | Miss |
| 06 Aug 2024 07:00 | -0.04 | 0.04 | +209.4% | Beat |
| 01 May 2024 07:00 | -0.04 | -0.07 | -55.6% | Miss |
| 28 Feb 2024 07:00 | -0.11 | -0.10 | +11.9% | Beat |
| 01 Nov 2023 07:00 | 0.10 | 0.73 | +660.4% | Beat |
| 01 Aug 2023 07:00 | -0.25 | -0.34 | -38.4% | Miss |
| 01 May 2023 07:00 | -0.34 | -0.28 | +18.0% | Beat |
| 28 Feb 2023 07:00 | -0.26 | -0.39 | -48.1% | Miss |
| 10 Nov 2022 07:00 | -0.38 | -0.26 | +31.0% | Beat |
| 08 Aug 2022 07:00 | -0.57 | -0.30 | +47.8% | Beat |
| 10 May 2022 16:00 | -0.63 | -0.51 | +19.0% | Beat |
| 01 Mar 2022 07:00 | -0.68 | -0.70 | -3.3% | Miss |
| 04 Nov 2021 07:00 | -0.57 | -0.65 | -13.7% | Miss |
| 02 Aug 2021 07:00 | -0.50 | -0.59 | -17.7% | Miss |
| 10 May 2021 07:00 | -0.50 | -0.69 | -38.5% | Miss |
| 01 Mar 2021 16:00 | -0.61 | -0.72 | -17.7% | Miss |
| 09 Nov 2020 16:00 | -0.44 | -0.73 | -65.2% | Miss |
| 10 Aug 2020 07:00 | -0.33 | -0.47 | -41.4% | Miss |
| 11 May 2020 16:00 | -0.37 | -0.48 | -28.0% | Miss |
| 02 Mar 2020 16:00 | -0.49 | -0.44 | +11.1% | Beat |
| 12 Nov 2019 07:00 | -0.35 | -0.69 | -94.4% | Miss |
| 09 Aug 2019 07:00 | -0.42 | -0.42 | 0.0% | In line |
| 10 May 2019 07:00 | -0.44 | -0.43 | +3.0% | Beat |
| 01 Mar 2019 16:00 | -0.42 | -0.69 | -62.4% | Miss |
| 09 Nov 2018 07:00 | -0.50 | -0.43 | +13.4% | Beat |
| 07 Aug 2018 16:00 | -0.50 | -0.59 | -18.0% | Miss |
| 08 May 2018 07:00 | -0.42 | -0.59 | -41.3% | Miss |
| 08 Mar 2018 07:00 | -0.41 | -0.46 | -12.2% | Miss |
| 08 Nov 2017 07:00 | -0.40 | -0.48 | -19.0% | Miss |
| 09 Aug 2017 07:00 | -0.38 | -0.45 | -18.4% | Miss |
| 05 May 2017 07:00 | -0.36 | -0.52 | -42.9% | Miss |
| 10 Mar 2017 07:00 | -0.35 | -0.48 | -37.9% | Miss |
| 07 Nov 2016 07:00 | -0.30 | -0.50 | -64.5% | Miss |
| 08 Aug 2016 07:00 | -0.27 | -0.33 | -20.4% | Miss |
| 10 May 2016 16:00 | -0.34 | -0.28 | +17.2% | Beat |
| 07 Mar 2016 16:00 | -0.30 | -0.37 | -24.2% | Miss |
| 09 Nov 2015 07:00 | -0.37 | -0.28 | +24.3% | Beat |
| 10 Aug 2015 07:00 | -0.33 | -0.38 | -14.0% | Miss |
| 04 May 2015 17:00 | -0.33 | -0.39 | -18.2% | Miss |
| 11 Mar 2015 17:00 | -0.25 | -0.48 | -88.2% | Miss |
| 10 Nov 2014 16:00 | -0.32 | -0.36 | -11.6% | Miss |
| 21 Jul 2014 16:00 | -0.21 | -0.36 | -67.4% | Miss |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 616.3M | +87.3% | 447.2M | 72.6% | 2.77 | +1,746.7% | -25M |
| 2024 | 329M | +40.8% | 23.4M | 7.1% | 0.15 | +66.7% | -40.6M |
| 2023 | 233.7M | +8,290.0% | 12.7M | 5.4% | 0.09 | +106.2% | -31.4M |
| 2022 | 2.8M | — | -223.8M | -8,036.3% | -1.46 | — | -176.2M |
| 2021 | — | — | — | — | — | — | — |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 12 Nov 2026 | 65.76 | 65.86 | 63.28 | 64.56 | -1.82% | 1,580,700 | |
| 11 Nov 2026 | 64.01 | 66.07 | 62.79 | 65.76 | +2.33% | 2,058,000 | |
| 10 Nov 2026 | 62.70 | 68.03 | 62.00 | 64.26 | +1.39% | 5,789,700 | |
| 09 Nov 2026 | 58.00 | 63.50 | 54.61 | 63.38 | +5.94% | 4,926,000 | |
| 06 Nov 2026 | 57.99 | 60.82 | 57.55 | 59.83 | +3.18% | 2,305,400 | |
| 05 Nov 2026 | 61.50 | 61.58 | 57.82 | 57.98 | -5.92% | 2,112,100 | |
| 04 Nov 2026 | 61.85 | 62.78 | 60.31 | 61.63 | +1.45% | 2,039,400 | |
| 03 Nov 2026 | 60.24 | 62.20 | 60.02 | 60.75 | +1.33% | 2,145,000 | |
| 02 Nov 2026 | 61.01 | 63.60 | 59.59 | 59.95 | -2.01% | 2,575,000 | |
| 30 Oct 2026 | 58.15 | 61.76 | 58.00 | 61.18 | +5.34% | 2,851,600 | |
| 1,249 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- The Zacks Analyst Blog Highlights TG Therapeutics, BioCryst, Insmed and Madrigal (opens in a new tab) Zacks · 11 Nov 2026 06:36
- TG Therapeutics (TGTX) Lifts Revenue Guidance As Investors Ask If The Stock Is Pricey (opens in a new tab) Simply Wall St. · 11 Nov 2026 03:12
- TG Therapeutics (TGTX) Stock Stays Hard To Justify Despite Raised Revenue Guidance (opens in a new tab) Simply Wall St. · 11 Nov 2026 02:20
- How IBD Stock Of The Day TG Therapeutics Is Catching Up To Roche, Novartis (opens in a new tab) Investor's Business Daily · 10 Nov 2026 22:12
- Is Earnings Beat Altering The Investment Case For TG Therapeutics (TGTX)? (opens in a new tab) Simply Wall St. · 10 Nov 2026 22:11
- TGTX Q3 Earnings & Revenues Beat Estimates, 2026 View Raised, Stock Up (opens in a new tab) Zacks · 10 Nov 2026 18:15
- 4 Commercial-Stage Biotechs Poised for Sustained Revenue Growth (opens in a new tab) Zacks · 10 Nov 2026 13:13
- Evercore ISI Group Maintains Outperform on TG Therapeutics, Lowers Price Target to $71 (opens in a new tab) Benzinga · 10 Nov 2026 10:12
- Company News for Nov 10, 2026 (opens in a new tab) Zacks · 10 Nov 2026 10:02
- TG Therapeutics, Inc. Q3 2026 Earnings Call Summary (opens in a new tab) Moby · 10 Nov 2026 03:11
- TG Therapeutics (TGTX) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 10 Nov 2026 02:03
- TG Therapeutics Inc (TGTX) (Q3 2026) Earnings Call Highlights: Revenue Jumps 61% as Guidance ... (opens in a new tab) GuruFocus.com · 09 Nov 2026 21:07
- What TG Therapeutics (TGTX) Said on Its Q3 Earnings Call (opens in a new tab) MarketBeat · 09 Nov 2026 18:14
- TG Therapeutics, Inc. (TGTX) Q3 2026 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 09 Nov 2026 17:01
- TG Therapeutics (NASDAQ:TGTX) Delivers Mixed Q3 2026 With Revenue Beat, EPS Miss, and Raised Guidance (opens in a new tab) ChartMill · 09 Nov 2026 13:31
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 65.76 USD
- Market cap
- 9.8B
- Exchange
- NasdaqCM
- Country
- United States
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow TGTX and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.